Moteur de recherche d’entreprises européennes

Financement de l’UE (3 139 984 €) : Manipulation des médicaments protéiques dans le monde réel - Exploration, évaluation et éducation Hor01/07/2021 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

Manipulation des médicaments protéiques dans le monde réel - Exploration, évaluation et éducation

RealHOPE will create an understanding of the real-life handling of protein drugs in hospital pharmacy, clinics and in the hands of patients by applying smart tag technologies. Different parameters will be logged and combined with protein characterisation at different stages, as well as with information from EFPIA partners on their drugs in use. Statistical evaluation of the data will be used to identify patterns in handling that are linked to protein destabilisation occurrence and type of protein degradation. Focus interviews with personnel in hospital pharmacies, clinics and with patients/care givers will be used to understand current handling practice and what the desired handling instructions and limitations are. These insights will be used to design in-use mimicking stability protocols for the protein drugs in the project. Ultra-scaled-down devices for stability assessment will be designed to be used in early phase for efficient development cost effective and safe future protein therapies. Protocols and devices will be validated towards the collected handling data base. Interventions in hospital pharmacies using e.g. compounding robots will be investigated. Techniques to assess e.g. aggregate formation in the final drug preparation situation will be evaluated together with SMEs producing analytical tools and hospital pharmacists. The collected data and interviews will form the base of development of teaching materials directed towards different target groups: hospital pharmacists, nurses and patients/care givers. App developers will be active in this part to design attractive and efficient apps for teaching and collecting therapy performance data.


Abbvie Inc. 0,00 €
Astrazeneca AB 0,00 €
Azienda Ospedaliera Universitaria Integrata Verona 15 285,00 €
Azienda Ulss N3 Serenissima 16 250,00 €
Boehringer Ingelheim Internationalgesellschaft mbH 0,00 €
Centre for Process Innovation Ltd. LBG 456 035 €
Elsa Science AB 98 702 €
F. Hoffmann-LA Roche AG 0,00 €
Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi i Sunyer 40 000 €
Hospital Clinic de Barcelona 0,00 €
ICU Medical B.V. 0,00 €
Istituto Oncologico Veneto 0,00 €
Lonza AG 0,00 €
Lunds Universitet 534 695 €
Merck KGaA 0,00 €
Pfizer Ltd. 0,00 €
Plurima S.p.A. 11 205,50 €
Probation Labs Sweden AB 28 048 €
Region Uppsala 130 445 €
Reumatikerforbundet 6 919,00 €
Rise Research Institutes OF Sweden AB 672 658 €
Sanofi-Aventis Deutschland GmbH 0,00 €
Societa Italiana Di Farmacia Clinica E Terapia 16 924,00 €
Teva Pharmaceutical Industries Ltd. 0,00 €
Universita Degli Studi Di Padova 272 500 €
University College London 325 349 €
University of Dundee 514 969 €

https://cordis.europa.eu/project/id/101007939

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.